According to Rohto Pharmaceutical's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.38997. At the end of 2023 the company had a P/S ratio of 2.48.
Year | P/S ratio | Change |
---|---|---|
2023 | 2.48 | 8.5% |
2022 | 2.28 | 15.59% |
2021 | 1.97 | -0.79% |
2020 | 1.99 |